SCHEMBL6677830

SCHEMBL6677830

O=C1CSCN1CCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.50
GSK3B P49841 2/20 0.50
KMT2A Q03164 3/20 0.49
GAA P10253 2/20 0.49
MAPT P10636 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 2/20 0.49
USP2 O75604 1/20 0.49
HTT P42858 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ACHE P22303 1/20 0.47
TAAR1 Q96RJ0 1/20 0.45
DAO P14920 2/20 0.45
MGLL Q99685 1/20 0.44
HPGD P15428 1/20 0.42
ALDH1A1 P00352 2/20 0.42
APAF1 O14727 1/20 0.42
CASP1 P29466 1/20 0.42
RAB9A P51151 1/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8595197 0.82 GSK3A (0.50) GSK3AGSK3BKMT2AMEN1HTT
SCHEMBL11513541 0.73 NPC1 (0.58) GSK3AGSK3BKMT2AGAAMAPT
SCHEMBL4283301 0.72 KMT2A (0.56) GSK3AGSK3BKMT2AGAAMAPT
SCHEMBL2182714 0.70 GAA (0.50) GSK3AGSK3BKMT2AGAAMAPT
SCHEMBL2132367 0.70 L3MBTL1 (0.60) KMT2AGAAMAPTHSD17B10MEN1
SCHEMBL31161862 0.70 ACHE (0.55) GSK3AGSK3BKMT2AGAAMAPT
SCHEMBL6298744 0.69 L3MBTL1 (0.54) GSK3AGSK3BKMT2AGAAMEN1
SCHEMBL6957614 0.69 ACHE (0.57) GSK3AGSK3BKMT2AGAAMAPT
SCHEMBL917005 0.69 L3MBTL1 (0.68) KMT2AGAAMAPTHSD17B10MEN1
SCHEMBL40440 0.68 KMT2A (0.67) GSK3AGSK3BKMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9351494-B2 Honeybee repellents and uses thereof INSCENT, INC. (US) 2016-05-31 US disclosed
US-20140329675-A1 Honeybee Repellents and Uses Thereof INSCENT, INC. (US) 2014-11-06 US disclosed
EP-0974073-B1 CHEMICAL SENSITIZATION OF PHOTOTHERMOGRAPHIC SILVER HALIDE EMULSIONS EASTMAN KODAK CO (US) 2004-11-17 EP disclosed
EP-0974073-A2 CHEMICAL SENSITIZATION OF PHOTOTHERMOGRAPHIC SILVER HALIDE EMULSIONS EASTMAN KODAK COMPANY (US) 2000-01-26 EP disclosed
US-5891615-A Chemical sensitization of photothermographic silver halide emulsions IMATION CORP. (US) 1999-04-06 US disclosed
WO-1998045754-A2 CHEMICAL SENSITIZATION OF PHOTOTHERMOGRAPHIC SILVER HALIDE EMULSIONS EASTMAN KODAK COMPANY (US) 1998-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329675-A1 Honeybee Repellents and Uses Thereof ACHE, AHNAK, L3MBTL3 GSK3A 4660/4885GSK3B 3834/4885KMT2A 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.